These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 21397755)
1. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients. Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941 [TBL] [Abstract][Full Text] [Related]
2. Rivastigmine Use in the Treatment of Antimuscarinic Delirium. Greene SC J Med Toxicol; 2023 Jul; 19(3):284-287. PubMed ID: 37204613 [No Abstract] [Full Text] [Related]
3. Cholinesterase inhibitor treatment in patients with delirium. de Pont AC; van Geer MA; Schultz MJ Lancet; 2011 Mar; 377(9769):899; author reply 901. PubMed ID: 21397757 [No Abstract] [Full Text] [Related]
4. Cholinesterase inhibitor treatment in patients with delirium. Berg RM; Möller K Lancet; 2011 Mar; 377(9769):900; author reply 901. PubMed ID: 21397758 [No Abstract] [Full Text] [Related]
5. Alzheimer's drug proves ineffective for delirium. Harv Ment Health Lett; 2011 Mar; 27(9):7. PubMed ID: 21476248 [No Abstract] [Full Text] [Related]